Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
- Conditions
- Sickle Cell Anemia
- Interventions
- Dietary Supplement: Gum Arabic
- Registration Number
- NCT02467257
- Lead Sponsor
- Al-Neelain University
- Brief Summary
The purpose of this study is to determine whether Gum Arabic is effective as fetal hemoglobin inducing agent for sickle cell anemia patients.
- Detailed Description
: High level of fetal haemoglobin (Hb F) decreases sickle cell anaemia (SCA) severity and leads to improved survival. Butyrate proved to increase HbF production in vivo and in vitro studies. Nonetheless, its short half-life limited its utilization in clinical practice. Gum Arabic (GA) is edible, dried, gummy exudate from Acacia Senegal tree. GA fermentation by colonic bacteria increases serum butyrate concentrations. The investigators hypothesized regular intake of GA will increase serum butyrate level. The latter will induce fetal hemoglobin production and ameliorate patients' symptoms. 47 patients hemoglobin SS aged 5-42 years, on regular follow up in Military hospital were recruited from April 2014 to January 2015 Patients received dose of G A 30g/day for 12 weeks. Hb F, complete blood count and Erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
- over 5 year old
- less t5han 50
- diagnosed with homozygous sickle cell anemia by Hb electrophoresis
- patients received blood transfusion within the last three months or admitted to the hospital within 2 weeks because of Sickle cell anemia -related events or crisis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intrevention arm Gum Arabic Patients received Gum Arabic as intervention
- Primary Outcome Measures
Name Time Method The primary endpoint of the study will be the level of fetal hemoglobin after three months 12 weeks fetal hemoglobin will be measured each month for three months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Military Hospital
πΈπ©Omdurman, Khartoum, Sudan